Le Lézard
Classified in: Health
Subject: PLW

Tivic Health Announces Issuance of Four Patents for ClearUP Sinus Pain Relief


SAN FRANCISCO, Sept. 29, 2020 /PRNewswire/ -- Tivic Health® Systems Inc., a leading bioelectronics medical device company, today announced that the U.S. Patent and Trademark Office has issued four patents for ClearUP® Sinus Pain Relief that cover the device, its interface and a number of features that allow it to be comfortable, effective and ergonomic. The company has an additional 14 patents pending in the U.S and abroad.

"Receiving these issued patents that cover current and future product development is an important milestone for the company," said Jennifer Ernst, CEO of Tivic Health. "Our four U.S. patents in combination with an additional 14 patents pending allow us to expand our intellectual property portfolio and scale our business commercialization in the U.S. and abroad. We are committed to leading the new wave of non-invasive, safe and drug-free devices designed for consumers with chronic medical conditions."  

The four patents issued for ClearUP address device specifications, comfort features, device performance during treatment, and future product developments.  The following patents have been issued to Tivic Health for ClearUP:

About ClearUP Sinus Pain Relief
Clinically proven, FDA cleared and CE Mark, ClearUP is a small handheld sinus device  that has no chemical side effects and is available over-the-counter without a prescription to help millions of allergy sufferers manage their sinus pain. ClearUP is a unique sinus pain machine, it uses gentle microcurrent waveforms to reduce sinus pain and is an example of bioelectronics, an emerging form of drug-free, non-invasive medicine to treat chronic conditions.

For more information and discounts: https://buyclearUP.com

Priced at $149 MSRP ClearUP can be purchased at Amazon, BestBuy.com, Walgreens.com, Sharper Image, Hammacher Schlemmer, Brookstone and https://tivichealth.com 

About Tivic Health
Founded in 2016, Tivic Health is part of a $6.2B global bioelectronics industry that is dedicated to harnessing the power of neuromodulation for home use products that treat chronic diseases and conditions and empower people to improve their health and quality of life. ClearUP has received awards from: Fast Company's 2020 World Changing Awards, Last Gadget Standing CES 2020, Digital Trends Best Health Gadgets CES 2020,  TIME's 2019 Best Inventions and CES 2020 Innovation Honoree Award. @TivicHealth 

 

SOURCE Tivic Health


These press releases may also interest you

at 17:25
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
JDRF-Authored Paper Shows Pathway to Accelerate Disease-Modifying Therapies for People with Type 1 Diabetes
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
TOP-RANKED HEALTHCARE CONSULTING FIRM EXPANDS ROSTER, DEEPENS LEADERSHIP
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...

More news about Health...


News published on and distributed by: